New treatment for psoriasis

Researchers from Ben-Gurion University and Teva have developed an improved version of an experimental medicine for the treatment of the chronic skin disease psoriasis. It inhibits the faulty immune system signal interleukin-17 that triggers the inflammation associated with psoriasis.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *